GRAPPA Treatment Recommendations: An Update From the 2020 GRAPPA Annual Meeting.
GRAPPA
psoriasis
psoriatic arthritis
Journal
The Journal of rheumatology. Supplement
ISSN: 0380-0903
Titre abrégé: J Rheumatol Suppl
Pays: Canada
ID NLM: 7806058
Informations de publication
Date de publication:
Jun 2021
Jun 2021
Historique:
entrez:
2
6
2021
pubmed:
3
6
2021
medline:
11
8
2021
Statut:
ppublish
Résumé
Throughout 2020, the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) has been working to update the GRAPPA treatment recommendations for psoriasis and psoriatic arthritis (PsA). The planned methodology for this update was published previously, and herein we provide an update on progress so far, including details of the systematic literature searches undertaken. GRAPPA is committed to regular updates of its treatment recommendations to incorporate the many significant therapeutic advances that have taken place in the PsA literature since the previous recommendation publication in 2015. The development and updating of treatment recommendations for optimal treatment approaches for patients with PsA has been an important mission of the GRAPPA since its inception. GRAPPA is currently finalizing domain-specific recommendations with an aim to produce updated treatment recommendations for publication in 2021.
Identifiants
pubmed: 34074672
pii: 97/0/65
doi: 10.3899/jrheum.201681
doi:
Types de publication
Congress
Langues
eng
Sous-ensembles de citation
IM
Pagination
65-66Informations de copyright
Copyright © 2021 by The Journal of Rheumatology.